PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZBH vs. LMAT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ZBH and LMAT is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ZBH vs. LMAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
0.05%
10.38%
ZBH
LMAT

Key characteristics

Sharpe Ratio

ZBH:

-0.44

LMAT:

2.21

Sortino Ratio

ZBH:

-0.48

LMAT:

3.13

Omega Ratio

ZBH:

0.94

LMAT:

1.40

Calmar Ratio

ZBH:

-0.24

LMAT:

4.56

Martin Ratio

ZBH:

-0.64

LMAT:

12.63

Ulcer Index

ZBH:

15.01%

LMAT:

5.97%

Daily Std Dev

ZBH:

21.72%

LMAT:

34.08%

Max Drawdown

ZBH:

-65.03%

LMAT:

-75.69%

Current Drawdown

ZBH:

-34.87%

LMAT:

-8.25%

Fundamentals

Market Cap

ZBH:

$21.20B

LMAT:

$2.23B

EPS

ZBH:

$5.24

LMAT:

$1.83

PE Ratio

ZBH:

20.33

LMAT:

54.13

PEG Ratio

ZBH:

1.40

LMAT:

2.17

Total Revenue (TTM)

ZBH:

$5.66B

LMAT:

$164.15M

Gross Profit (TTM)

ZBH:

$3.63B

LMAT:

$110.84M

EBITDA (TTM)

ZBH:

$1.81B

LMAT:

$46.59M

Returns By Period

In the year-to-date period, ZBH achieves a 3.72% return, which is significantly lower than LMAT's 7.51% return. Over the past 10 years, ZBH has underperformed LMAT with an annualized return of 0.45%, while LMAT has yielded a comparatively higher 30.37% annualized return.


ZBH

YTD

3.72%

1M

2.51%

6M

-0.25%

1Y

-10.42%

5Y*

-4.92%

10Y*

0.45%

LMAT

YTD

7.51%

1M

7.53%

6M

12.48%

1Y

73.21%

5Y*

23.22%

10Y*

30.37%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZBH vs. LMAT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH
The Risk-Adjusted Performance Rank of ZBH is 2525
Overall Rank
The Sharpe Ratio Rank of ZBH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 3333
Martin Ratio Rank

LMAT
The Risk-Adjusted Performance Rank of LMAT is 9494
Overall Rank
The Sharpe Ratio Rank of LMAT is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of LMAT is 9292
Sortino Ratio Rank
The Omega Ratio Rank of LMAT is 9191
Omega Ratio Rank
The Calmar Ratio Rank of LMAT is 9797
Calmar Ratio Rank
The Martin Ratio Rank of LMAT is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZBH vs. LMAT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZBH, currently valued at -0.44, compared to the broader market-2.000.002.004.00-0.442.21
The chart of Sortino ratio for ZBH, currently valued at -0.48, compared to the broader market-4.00-2.000.002.004.006.00-0.483.13
The chart of Omega ratio for ZBH, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.40
The chart of Calmar ratio for ZBH, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.244.56
The chart of Martin ratio for ZBH, currently valued at -0.64, compared to the broader market-10.000.0010.0020.0030.00-0.6412.63
ZBH
LMAT

The current ZBH Sharpe Ratio is -0.44, which is lower than the LMAT Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of ZBH and LMAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.44
2.21
ZBH
LMAT

Dividends

ZBH vs. LMAT - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 0.88%, more than LMAT's 0.65% yield.


TTM20242023202220212020201920182017201620152014
ZBH
Zimmer Biomet Holdings, Inc.
0.88%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%
LMAT
LeMaitre Vascular, Inc.
0.65%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%1.83%

Drawdowns

ZBH vs. LMAT - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum LMAT drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for ZBH and LMAT. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-34.87%
-8.25%
ZBH
LMAT

Volatility

ZBH vs. LMAT - Volatility Comparison

Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT) have volatilities of 5.73% and 5.46%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
5.73%
5.46%
ZBH
LMAT

Financials

ZBH vs. LMAT - Financials Comparison

This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab